Compare BPRN & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BPRN | STXS |
|---|---|---|
| Founded | 2007 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 238.8M | 210.0M |
| IPO Year | N/A | 2004 |
| Metric | BPRN | STXS |
|---|---|---|
| Price | $34.00 | $2.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $35.00 | $4.00 |
| AVG Volume (30 Days) | 11.2K | ★ 585.1K |
| Earning Date | 01-27-2026 | 11-11-2025 |
| Dividend Yield | ★ 4.11% | N/A |
| EPS Growth | ★ 62.30 | N/A |
| EPS | ★ 2.57 | N/A |
| Revenue | ★ $76,577,000.00 | $30,075,000.00 |
| Revenue This Year | $13.51 | $24.21 |
| Revenue Next Year | $6.01 | $29.83 |
| P/E Ratio | $13.25 | ★ N/A |
| Revenue Growth | 13.94 | ★ 19.62 |
| 52 Week Low | $27.25 | $1.54 |
| 52 Week High | $36.95 | $3.59 |
| Indicator | BPRN | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 45.42 | 62.79 |
| Support Level | $33.70 | $2.25 |
| Resistance Level | $36.70 | $2.77 |
| Average True Range (ATR) | 0.81 | 0.11 |
| MACD | -0.30 | 0.03 |
| Stochastic Oscillator | 9.23 | 72.94 |
Princeton Bancorp Inc is a banking company. It is a full-service financial institution that provides business and personal banking. Its personal banking and business banking services include checking accounts and savings accounts. It offers traditional retail banking services, one-to-four-family residential mortgage loans, multi-family and commercial mortgage loans, construction loans, commercial business loans, and consumer loans, including home equity loans and lines of credit. The Bank also has two retail branches and conducts loan origination activities in select areas of the New York City metropolitan area.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.